| NCT04841148 |
Avelumab or Hydroxychloroquine with or Without Palbociclib to Eliminate Dormant Breast Cancer |
| NCT06518057 |
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer |
| NCT06557057 |
Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk |
| NCT05461430 |
Mass Response of Tumor Cells As a Biomarker for Rapid Therapy Guidance (TraveraRTGx) |
| NCT04523857 |
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer |
| NCT06336148 |
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors |
| NCT06249048 |
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab |
| NCT04084730 |
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer |
| NCT05928325 |
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment |
| NCT06449222 |
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy |
| NCT06806930 |
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) |
| NCT00451022 |
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies |
| NCT05746325 |
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast Cancer |
| NCT06534125 |
Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women with Early-Stage Breast Cancer |
| NCT06671730 |
Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer |
| NCT05412225 |
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer |
| NCT05283330 |
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors |
| NCT04039230 |
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. |
| NCT04360330 |
SABER Study for Selected Early Stage Breast Cancer |
| NCT05037825 |
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors |
| NCT06630325 |
A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer |
| NCT06068257 |
Tumor-Derived FGF19 |
| NCT06324357 |
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread |
| NCT06586957 |
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors |
| NCT06026657 |
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer |
| NCT06726148 |
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors |
| NCT03863457 |
[18F] F-GLN by PET/CT in Breast Cancer |
| NCT04616248 |
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors |
| NCT06878248 |
A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer |
| NCT06115486 |
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer |
| NCT06778863 |
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation |
| NCT05768139 |
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors |
| NCT02476786 |
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score |
| NCT03589339 |
NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 Therapy |
| NCT06123286 |
Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms |
| NCT06400563 |
MRg-NIRS Imaging System Breast Cancer Trial |
| NCT04234386 |
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer |
| NCT04721886 |
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer |
| NCT02610439 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer |
| NCT04871139 |
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer |
| NCT01788839 |
Longitudinal Sexual and Reproductive Health Study of Women with Breast Cancer and Lymphoma |
| NCT05720039 |
Robotic vs. Open NSM for Early Stage Breast Cancer |
| NCT01042548 |
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum |
| NCT05810025 |
FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments |
| NCT03524430 |
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy |
| NCT04606030 |
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) |
| NCT06557148 |
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer |
| NCT03351348 |
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control |
| NCT06065748 |
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) |
| NCT06507930 |
The COMPASSION Study |
| NCT05238922 |
Study of INCB123667 in Subjects With Advanced Solid Tumors |
| NCT06657222 |
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors |
| NCT05553522 |
Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer |
| NCT06879522 |
Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors |
| NCT05968157 |
MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick |
| NCT06817226 |
BREAST Choice Decision Tool R21 |
| NCT06633926 |
Integrative Approaches for Cancer Survivorship (IACS3) |
| NCT05952557 |
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) |
| NCT03129139 |
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors |
| NCT06610539 |
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients |
| NCT05501886 |
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) |
| NCT04756765 |
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer |
| NCT04329065 |
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer |
| NCT06744465 |
NearWave Optical Molecular Monitoring |
| NCT06428682 |
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction |
| NCT05115474 |
Study of Screening Brain MRIs in Stage IV Breast Cancer |
| NCT05933265 |
Study of LP-184 in Patients With Advanced Solid Tumors |
| NCT04959474 |
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer |
| NCT02749474 |
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes |
| NCT06799065 |
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer |
| NCT06268665 |
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy |
| NCT06441474 |
Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women |
| NCT06297265 |
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery |
| NCT06904365 |
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women |
| NCT03090165 |
Ribociclib and Bicalutamide in AR+ TNBC |
| NCT06217874 |
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer |
| NCT05579366 |
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) |
| NCT05721976 |
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study |
| NCT06686394 |
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009) |
| NCT06731894 |
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors |
| NCT05020860 |
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer |
| NCT05627960 |
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies |
| NCT05484973 |
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss |
| NCT06450873 |
Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery |
| NCT06727773 |
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer |
| NCT06545331 |
Study of XB010 in Subjects With Solid Tumors |
| NCT05912231 |
Ultrahypofractionation and Normal Tissue Toxicity |
| NCT06953882 |
Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy |
| NCT05563220 |
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer |
| NCT05825482 |
Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout® |
| NCT05770531 |
Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy |
| NCT01530373 |
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients |
| NCT06954831 |
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer |
| NCT04998682 |
Prospective Evaluation of Targeted Axillary Dissection (TAD) |
| NCT05319873 |
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer |
| NCT03909282 |
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma |
| NCT05464082 |
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC |
| NCT04573231 |
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer |
| NCT04886531 |
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers |
| NCT06545682 |
Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) |
| NCT06106282 |
Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) |
| NCT03746431 |
A Phase 1 Study of [225Ac]-FPI-1434 Injection |
| NCT05123482 |
A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies |
| NCT04503265 |
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies |
| NCT05693766 |
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort |
| NCT06275126 |
Optimizing Surgical Decisions in Young Adults With Breast Cancer |
| NCT05289466 |
Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation. |
| NCT05868226 |
PRE-I-SPY Phase I/Ib Oncology Platform Program |
| NCT04768426 |
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer |
| NCT05183126 |
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer |
| NCT06533826 |
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd |
| NCT06393374 |
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) |
| NCT04567420 |
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE) |
| NCT03572374 |
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job |
| NCT05020574 |
Microbiome and Association With Implant Infections |
| NCT02918474 |
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer |
| NCT06100874 |
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) |
| NCT05931874 |
Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors |
| NCT02000089 |
The Cancer of the Pancreas Screening-5 CAPS5)Study |
| NCT06401889 |
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy |
| NCT06485089 |
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers |
| NCT06392789 |
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors |
| NCT05098210 |
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer |
| NCT05269381 |
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors |
| NCT06075810 |
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer |
| NCT06500481 |
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial |
| NCT05827081 |
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer |
| NCT06536881 |
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming |
| NCT05366881 |
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease |
| NCT07042581 |
A Study of Revaree Plus in People With Breast Cancer |
| NCT05138510 |
Sexual Health in Breast Cancer Patients |
| NCT05464810 |
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer |
| NCT06517212 |
Tirzepatide Weight Loss for MRD+ Early Breast Cancer |
| NCT05715255 |
Adaptive Symptom Self-Management Immunotherapy Study |
| NCT03513614 |
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS) |
| NCT04273555 |
Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients with Advanced PET/MR Imaging |
| NCT05301114 |
Social Risk Factors and Discrimination in Cancer Survivorship |
| NCT06500455 |
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain |
| NCT06504914 |
Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors |
| NCT06096623 |
The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment |
| NCT05871008 |
Integrated Actionable Aging Assessment for Cancer Patients Pilot |
| NCT05327608 |
Neoadjuvant Breast Cancer Time Restricted Eating |
| NCT03979508 |
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer |
| NCT05417308 |
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer |
| NCT06938581 |
ERAS Protocols in Breast Conserving Surgery |
| NCT05452681 |
Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors |
| NCT04541381 |
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care |
| NCT05900895 |
Estradiol Plus Olaparib for Breast Cancer (PHOEBE) |
| NCT06772181 |
A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation |
| NCT04389281 |
X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma |
| NCT06084481 |
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 |
| NCT06247995 |
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. |
| NCT06055881 |
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy |
| NCT06388304 |
THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence |
| NCT04314401 |
National Cancer Institute "Cancer Moonshot Biobank" |
| NCT05130801 |
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery |
| NCT05230810 |
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer. |
| NCT05219695 |
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI) |
| NCT04877912 |
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening |
| NCT07044310 |
5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss |
| NCT06749210 |
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY |
| NCT05396612 |
Role of the Immune Environment in Response to Therapy in Breast Cancer |
| NCT06305312 |
Community Services Navigation to Advance Health Equity in Breast Cancer Screening |
| NCT05705401 |
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer |
| NCT02333604 |
Cancer Experience Registry (CER) for Cancer Patients and Caregivers |
| NCT06745804 |
Study of 68Ga-R10602 |
| NCT05130840 |
Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer |
| NCT05372640 |
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors |
| NCT04365569 |
Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program |
| NCT06844669 |
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy |
| NCT06441890 |
BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer |
| NCT06067503 |
Biomarkers to Detect Endocrine Therapy Resistance |
| NCT04863443 |
Nonlinear Elasticity Mapping of Breast Masses |
| NCT04606446 |
Study of PF-07248144 in Advanced or Metastatic Solid Tumors |
| NCT06678269 |
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer |
| NCT04891068 |
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer |
| NCT05334069 |
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection |
| NCT05929768 |
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer |
| NCT06228768 |
Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer |
| NCT05245812 |
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy |
| NCT06465368 |
A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause |
| NCT06408168 |
Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial) |
| NCT06027268 |
Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer |
| NCT05703269 |
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy |
| NCT06215469 |
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) |
| NCT05490472 |
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors |
| NCT01035112 |
Magnetic Resonance Imaging of Breast Cancer |
| NCT06072612 |
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. |
| NCT04754412 |
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study |
| NCT06245889 |
PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC |
| NCT05896189 |
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors |
| NCT04854304 |
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts |
| NCT06418204 |
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics |
| NCT05607004 |
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer |
| NCT06336538 |
Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors |
| NCT05964504 |
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry) |
| NCT04644068 |
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies |
| NCT06246968 |
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer |
| NCT03050268 |
Familial Investigations of Childhood Cancer Predisposition |
| NCT05751668 |
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) |
| NCT05892068 |
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain |
| NCT03270072 |
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients |
| NCT06926868 |
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) |
| NCT06347068 |
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells |
| NCT06371768 |
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors |
| NCT04044872 |
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity |
| NCT06042569 |
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial |
| NCT05755269 |
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women |
| NCT02977468 |
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer |
| NCT05649072 |
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. |
| NCT04829604 |
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03) |
| NCT04265872 |
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC |
| NCT07047872 |
A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction |
| NCT06915168 |
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer |
| NCT06400472 |
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors |
| NCT06023576 |
A Study of Blood Pressure Control During Cancer Treatment |
| NCT05969860 |
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer |
| NCT05269160 |
Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ) |
| NCT05665660 |
Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening |
| NCT04550494 |
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations |
| NCT04614194 |
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib |
| NCT05000294 |
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types |
| NCT05076760 |
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors |
| NCT05417594 |
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies |
| NCT06827704 |
Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women |
| NCT00899301 |
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer |
| NCT05046301 |
Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications |
| NCT05837767 |
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue |
| NCT06086704 |
Study of 18F-FFNP Breast PET/MRI |
| NCT06643767 |
Evaluation of the Bexa Breast Examination |
| NCT05417867 |
Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer |
| NCT05023967 |
Metformin and Nightly Fasting in Women With Early Breast Cancer |
| NCT06239467 |
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer |
| NCT04994067 |
Intra-Operative Radiation Registry |
| NCT06562192 |
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers |
| NCT05086692 |
A Beta-only IL-2 ImmunoTherapY Study |
| NCT05846789 |
SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers |
| NCT06157892 |
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors |
| NCT06721065 |
A Study of Language Interpretation Solutions for People With Breast Cancer |
| NCT05107674 |
A Study of NX-1607 in Adults With Advanced Malignancies |
| NCT05458674 |
Tucatinib+Trastuzumab+Eribulin in HER2+ MBC |
| NCT03452774 |
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry |
| NCT04258280 |
Improving Genetic Counseling for BRCA+ Mothers |
| NCT05496829 |
IMPACT Trial: Intervention to iMProve AdherenCe Equitably |
| NCT05645380 |
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC |
| NCT05932862 |
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Patients With Advanced Solid Tumors |
| NCT05208762 |
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors |
| NCT06478589 |
Patient Priorities for Survivorship Care in Older Breast Cancer Survivors |
| NCT05736367 |
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer |
| NCT06361940 |
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients with Hormone Receptor-Positive HER2-negative Breast Cancer |
| NCT02772367 |
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients |
| NCT03823144 |
Intravital Microscopy in Human Solid Tumors |
| NCT05864144 |
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors |
| NCT05535192 |
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients |
| NCT04282044 |
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies |
| NCT05544929 |
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers |
| NCT05983380 |
The Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors |
| NCT06635980 |
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer |
| NCT05735080 |
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer |
| NCT06673329 |
Brodalumab in the Treatment of Immune-Related Adverse Events |
| NCT06252662 |
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies |
| NCT05304962 |
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer |
| NCT06896162 |
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival |
| NCT05464667 |
Preoperative Irradiation for Stage I Breast Cancer |
| NCT05684367 |
Exercise to ReGain Stamina and Energy (The EXERGISE Study) |
| NCT06559540 |
Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer |
| NCT03606967 |
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer |
| NCT05501704 |
ETHAN - ET for Male BC |
| NCT05795101 |
TRUDI: TDXD+Durva in HER2+/low IBC |
| NCT04134780 |
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response |
| NCT06022029 |
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. |
| NCT05620329 |
UNC Pleural Fluid Registry |
| NCT05143229 |
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer |
| NCT05704062 |
Quantitative MRI Assessment of Breast Cancer Therapy Response |
| NCT04561362 |
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies |
| NCT04722692 |
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ |
| NCT06092892 |
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases |
| NCT05472792 |
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy |
| NCT06295744 |
Outcomes and Cosmesis With Whole Breast Irradiation and Boost |
| NCT06568692 |
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer |
| NCT06538389 |
High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer |
| NCT06666192 |
The Ohio State University (OSU) SCREEN Community Program |
| NCT05056844 |
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge |
| NCT06993844 |
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors |
| NCT05059444 |
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation |
| NCT05537740 |
A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors |
| NCT04475640 |
Cancer Genetic Testing in Ethnic Populations |
| NCT05218044 |
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ |
| NCT06926920 |
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer |
| NCT03995082 |
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey |
| NCT05593094 |
A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Patients With HER2-Positive Advanced Solid Tumors |
| NCT05408260 |
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer |
| NCT05150691 |
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors |
| NCT06239194 |
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors |
| NCT06780176 |
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida |
| NCT05349227 |
Comprehensive Outcomes for After Cancer Health |
| NCT06399276 |
4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity |
| NCT04967976 |
Breast Mesh Used in Two-staged Breast Reconstruction |
| NCT06172127 |
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer |
| NCT06312176 |
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) |
| NCT05206331 |
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study |
| NCT07017673 |
Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer |
| NCT05092373 |
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax |
| NCT03562273 |
GammaPod Registry and Quality of Life Nomogram |
| NCT06081127 |
Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Function |
| NCT06923527 |
ctDNA Guided Adjuvant Treatment With Elacestrant: TBCRC-068 |
| NCT04824027 |
Breast Elasticity Imaging During Neoadjuvant Chemotherapy |
| NCT06638294 |
Study in Patients With Breast Cancer Leptomeningeal Metastasis |
| NCT00991094 |
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy |
| NCT05422794 |
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer |
| NCT05483491 |
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer |
| NCT05766891 |
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery |
| NCT05910294 |
A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer |
| NCT05655494 |
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials |
| NCT05556473 |
F-Tryptophan PET/CT in Human Cancers |
| NCT05856773 |
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy |
| NCT06471673 |
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer |
| NCT04796220 |
Focused Ultrasound and Gemcitabine in Breast Cancer |
| NCT05941520 |
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer |
| NCT04771520 |
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors |
| NCT04297020 |
Brain Health in Breast Cancer Survivors |
| NCT02926729 |
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy |
| NCT05440929 |
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians |
| NCT06435429 |
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer |
| NCT04510129 |
A Multicenter Cancer Biospecimen Collection Study |
| NCT04090567 |
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer |
| NCT06764940 |
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients with Brain Metastases |
| NCT02701244 |
A Registry Study of Breast Microseed Treatment |
| NCT03804944 |
Converting HR+ Breast Cancer Into an Individualized Vaccine |
| NCT04703244 |
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer |
| NCT03671044 |
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients |
| NCT05783622 |
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies |
| NCT05223322 |
Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction |
| NCT06388122 |
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients |
| NCT06767462 |
An Ophthalmic Safety Study in Patients With Breast Cancer |
| NCT05959291 |
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer |
| NCT06028022 |
Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors |
| NCT05879926 |
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 |
| NCT01441089 |
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis |
| NCT06748222 |
E-Mindfulness Approaches for Living After Breast Cancer |
| NCT05305365 |
Study Assessing QBS72S For Treating Brain Metastases |
| NCT06797635 |
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) |
| NCT05036096 |
Cone Beam Breast CT for Breast Cancer Screening |
| NCT05232916 |
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects |
| NCT05463796 |
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer |
| NCT04568616 |
Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) |
| NCT05716516 |
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER) |
| NCT06623396 |
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer |
| NCT05848141 |
Rowing Following Breast Cancer Chemotherapy |
| NCT04821141 |
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens |
| NCT06771219 |
SLV-154 Treatment of Metastatic Solid Tumors |
| NCT04794816 |
What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care |
| NCT04022616 |
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients |
| NCT05989724 |
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors |
| NCT04711824 |
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases |
| NCT06461416 |
A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework |
| NCT06113016 |
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors |
| NCT05351424 |
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc |
| NCT02830724 |
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers |
| NCT05377996 |
A Study of XMT-1660 in Participants With Solid Tumors |
| NCT05683418 |
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors |
| NCT04692818 |
3D Ultrasound Breast Imaging |
| NCT06105749 |
Biennial CEM in Women with a Personal History of Breast Cancer |
| NCT04270149 |
Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer |
| NCT05787834 |
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer |
| NCT04119024 |
Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors |
| NCT05305924 |
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer |
| NCT02290834 |
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer |
| NCT05468034 |
Exercise in Metastatic Breast Cancer: EMBody |
| NCT02422641 |
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis |
| NCT05386719 |
Cardiometabolic Screening Program |
| NCT05455619 |
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer |
| NCT04981119 |
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing |
| NCT06395519 |
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies |
| NCT06430541 |
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence |
| NCT04038619 |
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients |
| NCT05590949 |
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors |
| NCT04816006 |
Breast Cancer, Reasoning, and Activity Intervention |
| NCT05193149 |
Inspiratory Muscle Training in Obese Breast Cancer Survivors |
| NCT06858449 |
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer |
| NCT07064018 |
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies |
| NCT06526819 |
SMP-3124LP in Adults With Advanced Solid Tumors |
| NCT06760819 |
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) |
| NCT05056818 |
Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics |
| NCT01521741 |
Prospective Screening for Breast Cancer-related Lymphedema |
| NCT05748834 |
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer |
| NCT05607017 |
Losartan in Prevention of Radiation-Induced Heart Failure |
| NCT06714617 |
Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors |
| NCT05785741 |
A Study of DB-1310 in Advanced/Metastatic Solid Tumors |
| NCT03213041 |
Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer |
| NCT04722341 |
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators |
| NCT04557449 |
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors |
| NCT04371913 |
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study |
| NCT06827613 |
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors |
| NCT06395506 |
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation |
| NCT06195306 |
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction |
| NCT06085313 |
Cancer Pain Management Using a Web-based Intervention |
| NCT06112613 |
Mobile Health for Adherence in Breast Cancer Patients |
| NCT04890613 |
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation |
| NCT04222413 |
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors |
| NCT04851613 |
Study Evaluating Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients w/ Locally Advanced or Metastatic HR+/HER2- Breast Cancer |
| NCT06757634 |
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) |
| NCT05565417 |
Study of the Monoclonal Antibody IMT-009 in Patients with Advanced Solid Tumors or Lymphomas |
| NCT06582017 |
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma |
| NCT06610617 |
Neuromodulation of Central Sensory Integration to Improve Postural Control |
| NCT06750484 |
Trial of Trastuzumab Deruxtecan in Previously Treated HER2 |
| NCT05134779 |
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You |
| NCT06112379 |
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer |
| NCT06783179 |
Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement |
| NCT05675579 |
A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC) |
| NCT06136884 |
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors |
| NCT06150664 |
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies |
| NCT06943521 |
A Study of MT-4561 in Patients With Various Advanced Solid Tumors |
| NCT06238921 |
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases |
| NCT05786664 |
Breast Cancer Survivorship Biorepository |
| NCT05741164 |
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer |
| NCT01174121 |
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer |
| NCT06257264 |
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors |
| NCT06873802 |
ZTE MRI Pulse Sequence Use for Visualization of Bone Cement, Breast Biopsy Markers |
| NCT06580002 |
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial |
| NCT06833502 |
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer |
| NCT04990921 |
Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer |
| NCT06036121 |
A Study of ADRX-0706 in Select Advanced Solid Tumors |
| NCT04368702 |
CONFIRM: Magnetic Resonance Guided Radiation Therapy |
| NCT06401421 |
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) |
| NCT06982521 |
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer |
| NCT06105684 |
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer |
| NCT05677802 |
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer |
| NCT05935384 |
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation |
| NCT05949021 |
OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer |
| NCT06272864 |
BostonGene and Exigent Genomic INsight Study |
| NCT05559164 |
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted |
| NCT04354064 |
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors |
| NCT06330064 |
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) |
| NCT06103864 |
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer |
| NCT04965064 |
Trial of Neratinib Plus Capecitabine in Subjects with HER2-Negative Metastatic Breast Cancer with Brain Metastases and Abnormally Active HER2 Signaling |
| NCT05755984 |
3D Printed Breast Models in the Surgical Management of Breast Cancer |
| NCT03011684 |
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial |
| NCT02945579 |
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy |
| NCT06728579 |
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors |
| NCT05633979 |
Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer |
| NCT05378464 |
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer |
| NCT06144164 |
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer |
| NCT04521764 |
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer |
| NCT05507879 |
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer |
| NCT04762979 |
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer |
| NCT06831084 |
Acute Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer Patients With the Use of Silver-Plated Technology |
| NCT05870579 |
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer |
| NCT06127979 |
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery |
| NCT04683679 |
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer |
| NCT04986579 |
Scalp Cooling in MBC |
| NCT01042379 |
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer |
| NCT04968964 |
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing |
| NCT05826964 |
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer |
| NCT06434064 |
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer |
| NCT04373564 |
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years |
| NCT04913064 |
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer |
| NCT05598879 |
Global Cardio Oncology Registry |
| NCT06238479 |
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors |
| NCT04088708 |
Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors |
| NCT04144023 |
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ |
| NCT04899908 |
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases |
| NCT04049214 |
Perioperative Mindfulness Proposal |
| NCT06220214 |
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer |
| NCT06833255 |
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York |
| NCT06049355 |
EMBRACE: Exercising Together |
| NCT05309655 |
Cardiac Outcomes With Near-Complete Estrogen Deprivation |
| NCT06617455 |
Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial |
| NCT07040514 |
24GUT540 : Meeting of Breast Cancer Patients and Pathologists |
| NCT06938555 |
The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors |
| NCT06966050 |
Multi-center MRD Registry for Inflammatory Breast Cancer |
| NCT04585750 |
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) |
| NCT06981208 |
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction |
| NCT05919108 |
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers |
| NCT05534438 |
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer |
| NCT05972343 |
COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients |
| NCT04379414 |
YES Study - Newly Diagnosed/Metastatic Intervention |
| NCT05827614 |
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications |
| NCT03137095 |
Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI |
| NCT06961955 |
5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer |
| NCT03987555 |
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients |
| NCT05013255 |
Pioglitazone Therapy Targeting Fatigue in Breast Cancer |
| NCT06643455 |
Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND Trial |
| NCT05837455 |
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer |
| NCT06461650 |
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction |
| NCT06184750 |
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial |
| NCT05676255 |
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project |
| NCT05974150 |
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring |
| NCT05014295 |
Patient Recall of Cancer Screening and Diagnosis |
| NCT05780814 |
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer |
| NCT05933395 |
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor |
| NCT01503190 |
The Immune System's Response to Young Women's Breast Cancer |
| NCT06580743 |
Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer |
| NCT04766190 |
DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer |
| NCT06327490 |
A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer |
| NCT05126290 |
CTNNA1 Familial Expansion Study |
| NCT04916990 |
Improving Care for Rural Patients With Solid Tumors |
| NCT05074290 |
Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients |
| NCT06179303 |
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer |
| NCT06218303 |
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ |
| NCT05005403 |
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab |
| NCT06409390 |
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer |
| NCT06099769 |
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer |
| NCT06103669 |
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS) |
| NCT05546268 |
Study of Oral MRT-2359 in Selected Cancer Patients |
| NCT06524895 |
Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery |
| NCT06444269 |
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial |
| NCT05369546 |
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis |
| NCT05654246 |
Susan G. Komen's ShareForCures |
| NCT05318469 |
Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer |
| NCT05049746 |
Identifying Decision Making Needs for Older Adult Women with Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy |
| NCT02735746 |
Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis |
| NCT06187103 |
Evaluation of Improved Onboard Patient Imaging |
| NCT06956690 |
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ENV-501 in Patients With HER3-Expressing Solid Tumors |
| NCT05592938 |
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) |
| NCT05030038 |
Oral Aromatase Inhibitors Modify the Gut Microbiome |
| NCT03449238 |
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients |
| NCT05069038 |
Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy |
| NCT05505643 |
Cryoablation vs Lumpectomy in T1 Breast Cancers |
| NCT06185738 |
WeCanManage. An mHealth Self-management Tool |
| NCT06263543 |
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW MBC |
| NCT06422455 |
Access to Genetic Testing in Underserved Patients With Cancer |
| NCT05841355 |
MADRE (Mammograms Available Due to Research and Education) |
| NCT04003038 |
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery |
| NCT06016738 |
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer |
| NCT06831838 |
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors |
| NCT06058650 |
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities |
| NCT04517838 |
Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer |
| NCT05386108 |
Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to ER+/HER-2- Breast Cancer |
| NCT06512350 |
Identifying Patterns in the Breath of Individuals With Breast Cancer |
| NCT06572410 |
Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision |
| NCT06671912 |
Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial |
| NCT05259410 |
Time Restricted Eating During Chemotherapy for Breast Cancer |
| NCT04636710 |
Refining Local-Regional Therapy for IBC |
| NCT06037954 |
A Study of Mental Health Care in People With Cancer |
| NCT06584396 |
Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study |
| NCT05637216 |
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients |
| NCT04677816 |
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients |
| NCT06492616 |
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence |
| NCT06551116 |
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer |
| NCT03990896 |
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial |
| NCT00034216 |
Collection of Blood From Patients With Cancer |
| NCT04715958 |
Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasound in Patients With Locally Advanced Breast Cancer |
| NCT05455658 |
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer |
| NCT05226663 |
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer |
| NCT06100263 |
Breast Cancer Resiliency Through Exercise Program (B-REP) |
| NCT02743858 |
Lymphedema Surveillance Study |
| NCT06162663 |
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors |
| NCT04914663 |
All-extremity Exercise During Breast Cancer Chemotherapy |
| NCT03546686 |
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women with Triple-negative Breast Cancer |
| NCT06774963 |
A Phase 1 Study of LNCB74 in Advanced Solid Tumors |
| NCT02896335 |
Palbociclib and Pembrolizumab In Central Nervous System Metastases |
| NCT04862663 |
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292) |
| NCT04799535 |
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring |
| NCT04961996 |
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) |
| NCT04969835 |
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours |
| NCT06691035 |
Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer |
| NCT07071896 |
Strong Survivors: A Video-assisted Exercise Program for the Geriatric Breast Cancer Patient |
| NCT06428396 |
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) |
| NCT04457596 |
T-DM1 and Tucatinib Compared with T-DM1 Alone in Preventing Relapses in People with High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial |
| NCT02610426 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer |
| NCT05696626 |
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation |
| NCT07109726 |
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations |
| NCT06130826 |
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer |
| NCT06399757 |
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors |
| NCT05056857 |
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen |
| NCT02595957 |
Genomic Services Research Program |
| NCT06590857 |
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. |
| NCT04904757 |
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening |
| NCT06666439 |
Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer |
| NCT05900986 |
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer |
| NCT05894239 |
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer |
| NCT06315296 |
An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer |
| NCT00291096 |
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer |
| NCT06500858 |
MBC Physical Activity Study |
| NCT04331535 |
The Genomic Medicine at VA Study |
| NCT04751435 |
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients |
| NCT05877859 |
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab |
| NCT03796559 |
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes |
| NCT04787042 |
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 |
| NCT06085742 |
BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer |
| NCT05561842 |
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries) |
| NCT06242470 |
A Study of MGC026 in Participants With Advanced Solid Tumors |
| NCT06036875 |
CARE: Cancer Risk Perception and Women of Color |
| NCT04983875 |
Mammography and Breast Arterial Calcification: an Information-Sharing Trial |
| NCT05694559 |
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics |
| NCT05394259 |
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer |
| NCT04020575 |
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) |
| NCT05508906 |
Phase 1b Combo w/ Ribociclib, Alpelisib, or Everolimus |
| NCT04169542 |
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery |
| NCT06515470 |
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer |
| NCT04379570 |
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy |
| NCT06134375 |
A Study of Tetrathiomolybdate (TM) Plus Capecitabine |
| NCT06008275 |
Neratinib in Combination With Ruxolitinib in Patients With mTNBC |
| NCT06625775 |
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors |
| NCT06374459 |
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis |
| NCT06559059 |
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs |
| NCT06270706 |
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors |
| NCT05824975 |
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) |
| NCT07007559 |
ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies |
| NCT06679400 |
Effects of Myofascial Massage and Patient-therapist Communication Levels on Shoulder Muscle Properties in Breast Cancer Survivors With Myofascial Pain |
| NCT05315700 |
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration |
| NCT06966700 |
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) |
| NCT06350500 |
A Patient Navigation Program for Addressing Disparities in Breast Cancer Care |
| NCT06572800 |
Tka Assay for CDK4/6i |
| NCT00477100 |
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients with Inflammatory or Invasive Breast Cancer |
| NCT06006299 |
Investigating the Use of TaVNS to Treat Insomnia in Individuals with Breast Cancer (taVNS-insomnia-BC) |
| NCT07020117 |
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors |
| NCT04115306 |
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer |
| NCT03897270 |
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects |
| NCT06545942 |
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors |
| NCT04553770 |
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer |
| NCT05703399 |
Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study |
| NCT05754658 |
African Cancer Genome: GMD |
| NCT05565534 |
Diabetes Care for Breast Cancer Patients |
| NCT05514717 |
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 |
| NCT07029399 |
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors |
| NCT06349642 |
Predicting Response to Immune Checkpoint Inhibitors Across Solid Tumors Using a Live Tumor Diagnostic Platform |
| NCT03096418 |
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response |
| NCT06534918 |
Precise Oncology Interventions in Nutrition and Training (OnPoint) |
| NCT04150042 |
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells |
| NCT06165419 |
Definitive Radiation for High-Risk Spine Metastases |
| NCT06827236 |
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer |
| NCT05977036 |
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer |
| NCT04485013 |
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers |
| NCT05035836 |
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) |
| NCT05913713 |
HIIT Following Breast Cancer Chemotherapy |
| NCT02610413 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer |
| NCT03769415 |
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA |
| NCT06369285 |
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer |
| NCT03941756 |
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma |
| NCT04650256 |
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences |
| NCT04030507 |
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer |
| NCT06171607 |
Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses |
| NCT04893109 |
ATEMPT 2.0: Adjuvant T-DM1 vs TH |
| NCT06123988 |
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer |
| NCT04332588 |
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI |
| NCT05889988 |
A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients |
| NCT06960707 |
Two Versus One Week Breast Radiotherapy (RT) |
| NCT04720209 |
Taking AIM at Breast Cancer |
| NCT06860815 |
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer |
| NCT06518837 |
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer |
| NCT06230185 |
CtDNA Based MRD Testing for NAC Monitoring in TNBC |
| NCT03604315 |
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF |
| NCT07071415 |
Overdiagnosis and Breast Cancer Screening Decisions |
| NCT03400215 |
Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer |
| NCT04397185 |
Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer |
| NCT06625515 |
First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers |
| NCT06361056 |
Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials |
| NCT03740256 |
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors |
| NCT03694756 |
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer |
| NCT05704283 |
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer |
| NCT05989347 |
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy |
| NCT06058377 |
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer |
| NCT06085833 |
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions |
| NCT06898333 |
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening |
| NCT01034033 |
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples |
| NCT04315233 |
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics |
| NCT05978128 |
Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants |
| NCT06910761 |
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer |
| NCT03643861 |
RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI) |
| NCT04468061 |
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC |
| NCT06405828 |
Enhancing Access to Supportive Services for Women of Color with Metastatic Breast Cancer |
| NCT05183828 |
Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer |
| NCT06610097 |
TNBC Gut Microbiota During Neoadjuvant Treatment |
| NCT06483997 |
Diet, Hepcidin, and Chemotherapy RDI |
| NCT01766297 |
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer |
| NCT06773897 |
Rutgers University Study of the Genetics of Breast Cancer. |
| NCT06127797 |
Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue |
| NCT03424005 |
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer |
| NCT06635005 |
A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women |
| NCT04704661 |
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial |
| NCT06781983 |
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors |
| NCT03934905 |
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction |
| NCT06451497 |
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors |
| NCT02807597 |
Real-time Intraoperative Breast Cancer Visualization for Margin Assessment |
| NCT05746897 |
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors |
| NCT06185205 |
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy |
| NCT05146297 |
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials |
| NCT06078761 |
Healthy Eating and Active Lifestyle (HEAL): Breast Cancer Program Outcomes |
| NCT04815083 |
Fluorescence Imaging of Carcinoma During Breast Conserving Surgery |
| NCT04494945 |
Identifying and Caring for Individuals With Inherited Cancer Syndrome |
| NCT05064098 |
Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients |
| NCT06995898 |
The Vanguard Study: Testing a New Way to Screen for Cancer |
| NCT05108298 |
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials |
| NCT05178498 |
Impact of Dietary Inflammatory Potential on Breast Cancer Risk |
| NCT06460298 |
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer |
| NCT05114005 |
Tango for Neuropathy Among Breast Cancer Survivors |
| NCT03742245 |
Olaparib in Combination with Vorinostat in Patients with Relapsed/Refractory And/or Metastatic Breast Cancer |
| NCT06293898 |
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors |
| NCT05488145 |
A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy |
| NCT06763328 |
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy |
| NCT03556228 |
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma |
| NCT06120283 |
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors |
| NCT05930483 |
Remotely Delivered, Culturally Tailored Weight Loss Interventions Among Latina Breast Cancer Survivors |
| NCT05111561 |
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer |
| NCT01000883 |
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior |
| NCT06043661 |
Early Detection of Breast Cancer |
| NCT06840483 |
Study to Assess Clinical Activity of Zelenectide Pevedotin in Participants With Advanced Breast Cancer |
| NCT00353483 |
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells |
| NCT05660083 |
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) |
| NCT05483283 |
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care |
| NCT06176261 |
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs |
| NCT03451383 |
Older Breast Cancer Patients: Risk for Cognitive Decline |
| NCT05298605 |
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women |
| NCT06353997 |
Neoadjuvant INBRX-106 (Hexavalent OX40 Agonist) in Combination With Pembrolizumab as a Chemotherapy-sparing Regimen for Stage II TNBC (Triple Negative Breast Cancer) Patients |
| NCT06440005 |
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors |
| NCT05659797 |
FES BPET-DBT in Newly Diagnosed Breast Cancer |
| NCT06672497 |
Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients |
| NCT04075305 |
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study |
| NCT05774678 |
Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Nanomechanical Biomarker Evaluation |
| NCT04180371 |
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression |
| NCT05716893 |
Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer |
| NCT06258993 |
A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation |
| NCT06784193 |
Study of OP-3136 in Advanced or Metastatic Solid Tumors |
| NCT05042687 |
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer |
| NCT04569747 |
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer |
| NCT06106477 |
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer |
| NCT03412877 |
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer |
| NCT05967533 |
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors |
| NCT06260033 |
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer |
| NCT05528133 |
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer |
| NCT05142033 |
Avera Cancer Sequencing and Analytics Protocol (ASAP) |
| NCT06681233 |
Feasibility Study of CBCT for IGRT in Cancer Patients |
| NCT00823654 |
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations |
| NCT04378751 |
Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer |
| NCT07068477 |
Adaptation of a Values Assessment Tool |
| NCT06966453 |
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer |
| NCT03697577 |
CDK and Body Composition Study |
| NCT05921253 |
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy |
| NCT05288777 |
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer |
| NCT05774951 |
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy |
| NCT06380751 |
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer |
| NCT05890677 |
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema |
| NCT06075953 |
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment |
| NCT06456411 |
Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer |
| NCT05368428 |
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer |
| NCT06300411 |
SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery |
| NCT06790693 |
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer |
| NCT06253871 |
A Phase 1/1b Study of IAM1363 in HER2 Cancers |
| NCT05645471 |
Together After Cancer |
| NCT05226871 |
Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies |
| NCT03488693 |
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer |
| NCT05438511 |
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania |
| NCT05989828 |
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer |
| NCT06336928 |
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis |
| NCT03418961 |
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer |
| NCT04454528 |
BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy |
| NCT05225428 |
Video Education With Result Dependent dIsclosure |
| NCT03723928 |
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer |
| NCT05902988 |
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer |
| NCT05996107 |
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, Node Positive, HR+/HER2- Breast Cancer |
| NCT05081609 |
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies |
| NCT04230109 |
Sacituzumab Govitecan In TNBC |
| NCT05291507 |
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System |
| NCT05504707 |
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer |
| NCT05035407 |
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers |
| NCT04563507 |
Combined Immunotherapies in Metastatic ER+ Breast Cancer |
| NCT07060807 |
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) |
| NCT05095207 |
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer |
| NCT06072807 |
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer |
| NCT06555588 |
Engage Psychosocial Intervention for Cancer Symptoms |
| NCT06638307 |
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer |
| NCT05984888 |
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer |
| NCT04427293 |
Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC) |
| NCT06902311 |
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) |
| NCT05710328 |
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial |
| NCT04143711 |
Study of DF1001 in Patients with Advanced Solid Tumors |
| NCT06169371 |
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI) |
| NCT06110793 |
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer |
| NCT06052488 |
Strength After Breast Cancer |
| NCT05585788 |
Opioid Dispensing Device for Post-Operative Pain in Cancer Patients |
| NCT06322888 |
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D) |
| NCT05812807 |
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab |
| NCT06888388 |
Long-term Safety of Nipple Sparing Mastectomy in Women With GPV in Breast Cancer |
| NCT05960188 |
Project 1: Self-Triage by 2D Full-field Digital Mammography or Synthetic Images |
| NCT03936478 |
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer |
| NCT06604078 |
Breast Cancer AI Imaging Study |
| NCT05703178 |
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia |
| NCT06488378 |
Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer |
| NCT05376878 |
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis |
| NCT04300556 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types |
| NCT05243056 |
A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment |
| NCT06271356 |
Breast Cancer - Navigate - Prospective Cohort |
| NCT06439693 |
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer |
| NCT04997993 |
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer |
| NCT06682793 |
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression |
| NCT05891171 |
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers |
| NCT05190978 |
Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction |
| NCT03053193 |
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles |
| NCT05150652 |
Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer |
| NCT05809752 |
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) |
| NCT02620852 |
Women Informed to Screen Depending on Measures of Risk (Wisdom Study) |
| NCT05053152 |
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study |
| NCT06533059 |
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors |
| NCT05625659 |
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts |
| NCT04802759 |
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer |
| NCT05673200 |
Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer |
| NCT05653752 |
A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer |
| NCT05608252 |
VS-6766+Abema+Fulv in Met HR+/HER- BC |
| NCT06377852 |
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study |
| NCT05612100 |
Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients |
| NCT04305834 |
Abemaciclib and Endocrine Therapy in Older Patients with Breast Cancer. |
| NCT05812924 |
A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause |
| NCT05268224 |
A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue |
| NCT06291324 |
WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment |
| NCT06756932 |
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer |
| NCT06475937 |
A Study of DM001 in Patients With Advanced Solid Tumors |
| NCT05325632 |
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab |
| NCT03808337 |
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease |
| NCT06153836 |
Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction |
| NCT04333706 |
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER) |
| NCT05754749 |
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions |
| NCT05704842 |
Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy |
| NCT05382299 |
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer |
| NCT04174742 |
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer |
| NCT07020806 |
[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC) |
| NCT06006806 |
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy |
| NCT05898399 |
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients |
| NCT02012699 |
Integrated Cancer Repository for Cancer Research |
| NCT05957042 |
Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI). |
| NCT06351332 |
ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in MTNBC |
| NCT05187832 |
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer |
| NCT06018337 |
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) |
| NCT05654532 |
Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer |
| NCT06760637 |
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease |
| NCT05667532 |
The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts |
| NCT06954337 |
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial |
| NCT05768932 |
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia |
| NCT06334432 |
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors |
| NCT04985032 |
Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) |
| NCT04923542 |
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases |
| NCT05877599 |
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation |
| NCT05029999 |
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer |
| NCT04724499 |
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy |
| NCT02302742 |
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry |
| NCT05595499 |
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors |
| NCT05374915 |
Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC) |
| NCT03729115 |
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer |
| NCT06582615 |
Food for Thought - a Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer |
| NCT04763915 |
Improving Care After Inherited Cancer Testing |
| NCT05216432 |
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, As a Single Agent in Advanced Solid Tumor Patients and in Combination with Fulvestrant in Patients with Advanced Breast Cancer |
| NCT04450732 |
Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors |
| NCT02250352 |
Core Biopsies for Establishing a Breast Tumor Tissue Repository |
| NCT05983432 |
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors |
| NCT04458532 |
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer |
| NCT04837209 |
Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer |
| NCT04895709 |
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors |
| NCT04603209 |
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer |
| NCT05323409 |
Improving Comprehensive Care of Cancer Patients |
| NCT05313191 |
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors |
| NCT07118176 |
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers |
| NCT04872166 |
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer |
| NCT04074720 |
Prospective Breast Cancer Biospecimen Collection |
| NCT05573126 |
Phase 1/2 Study to Evaluate Vosilasarm (EP0062) as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer |
| NCT06188520 |
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors |
| NCT06253520 |
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer |
| NCT05467891 |
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer |
| NCT06894771 |
A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001) |
| NCT06637306 |
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer |
| NCT04174352 |
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer |
| NCT06700070 |
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors |
| NCT02732171 |
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer |
| NCT03408353 |
Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study |
| NCT03983577 |
Efficacy of Point Of Service Testing in MBC |
| NCT04638751 |
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients |
| NCT06435351 |
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy |
| NCT04852887 |
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) |
| NCT05595577 |
Improving Exercise Capacity With a Tailored Physical Activity Intervention |
| NCT05277051 |
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors |
| NCT05633654 |
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) |
| NCT06841354 |
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) |
| NCT06813053 |
A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer |
| NCT03463954 |
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors |
| NCT03255577 |
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer |
| NCT03937154 |
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer |
| NCT05514054 |
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer |
| NCT05787587 |
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors |
| NCT06577987 |
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies |
| NCT06864754 |
WashU DIEP Flap Video and Patient Understanding Improvement |
| NCT06334354 |
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC) |
| NCT05867251 |
Study of AVZO-021 in Patients With Advanced Solid Tumors |
| NCT07023887 |
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning |
| NCT06789653 |
A Novel Approach Utilizing Organ Specific Age Proteomics |
| NCT06397651 |
A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of Care |
| NCT02253251 |
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment |
| NCT03321045 |
Positron Emission Tomography (PET) Imaging with Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness |
| NCT06129747 |
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast |
| NCT06133647 |
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System |
| NCT06586047 |
Breast Cancer PSMA PET |
| NCT07076147 |
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer |
| NCT05296798 |
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) |
| NCT04588545 |
Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease |
| NCT05950945 |
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer |
| NCT06695845 |
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors |
| NCT06878547 |
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients |
| NCT04348747 |
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer |
| NCT06545045 |
Cognitive Rehabilitation Following Breast Cancer Treatment |
| NCT06285747 |
A Correlational Study: Breast Cancer-related Chest Wall Lymphedema, Quality of Life, and Shoulder Function |
| NCT03824145 |
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer |
| NCT06953245 |
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy |
| NCT05256745 |
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer |
| NCT05564377 |
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial |
| NCT05557877 |
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer |
| NCT05570253 |
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer |
| NCT05056077 |
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) |
| NCT06760507 |
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics |
| NCT06318507 |
The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy |
| NCT06139107 |
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole |
| NCT03971409 |
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer |
| NCT05941507 |
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors |
| NCT03789097 |
Vaccination With Flt3L, Radiation, and Poly-ICLC |
| NCT03536897 |
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry |
| NCT06603597 |
HER2-positive Breast Cancer Registry |
| NCT05830097 |
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors |
| NCT06318897 |
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer |
| NCT05327452 |
Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study |
| NCT05406232 |
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer |
| NCT05334732 |
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters) |
| NCT01185132 |
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy |
| NCT04389632 |
A Study of Sigvotatug Vedotin in Advanced Solid Tumors |
| NCT06011434 |
Testing Conversation Aid in Practice |
| NCT06274034 |
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors |
| NCT05297734 |
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer |
| NCT06507618 |
Pre-Operative Window of ET to Inform RT Decisions (POWER II) |
| NCT03165487 |
Comparison of the Breast Tumor Microenvironment |
| NCT06855654 |
Promoting Resilience in Women With Breast Cancer (PRISM -MBC) |
| NCT06999187 |
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas |
| NCT06414733 |
HER-2 B Cell Peptide Vaccine |
| NCT04526587 |
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors |
.jpg)
